Search - tctmd.com

Displaying 741 - 760 of 904

Sort: Relevancy | Date

Presentation JIM 2020

Onyx ONE: data, details and relevance to your clinical practice

Presenter: Gennaro Sardella

February 14, 2020

Presentation JIM 2020

Must Knows About Left Main PCI Outcomes (or Why was EXCEL so Controversial?)

Presenter: Gregg Stone

February 14, 2020

Presentation JIM 2020

Onyx in hbr-a case based

Presenter: Manoj Kumar

February 14, 2020

Presentation JIM 2020

PCI in a Patient Awaiting Liver Transplant

Presenter: Praveen Kulkarni

February 14, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

Presentation JIM 2020

Acute Mitral Apparatus Dimension Improvements Lead to Durable, Long-term Efficacy: Carillon Mitral Contour System® Case Presentation

Presenter: Michael Haude

February 13, 2020

Presentation JIM 2020

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Presenter: Giuseppe Tarantini

February 13, 2020

Presentation JIM 2020

Long-term antithrombotic therapy in high-risk PCI patients

Presenter: Alberto Menozzi

February 13, 2020

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Presentation JIM 2020

Ultra LOW LDL is the target for high risk patients

Presenter: Francesco Prati

February 13, 2020

Presentation JIM 2020

Optimal LDL Levels In Patients With ACS Undergoing PCI Clinical Case: PCI In ACS Patients With Multivessel Disease

Presenter: Ferdinando Varbella

February 13, 2020

Presentation JIM 2020

Tips And Tricks In Retrograde CTO PCI

Presenter: Roberto Garbo

February 13, 2020

Presentation JIM 2020

Antegrade Tips & Tricks

Presenter: Jacopo Oreglia

February 13, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Presentation JIM 2020

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Presenter: Marco Ferlini

February 13, 2020

Presentation JIM 2020

Technical innovations in CTO

Presenter: Mauro Carlino

February 13, 2020

Presentation JIM 2020

PCI in a NSTEMI patient When less is more…

Presenter: Baralis Giorgio

February 13, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation JIM 2020

The Abluminus DES+: from the technical features to the clinical program

Presenter: Luca Testa

February 13, 2020

Advertisement

Onyx ONE: data, details and relevance to your clinical practice

Must Knows About Left Main PCI Outcomes (or Why was EXCEL so Controversial?)

Onyx in hbr-a case based

PCI in a Patient Awaiting Liver Transplant

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Acute Mitral Apparatus Dimension Improvements Lead to Durable, Long-term Efficacy: Carillon Mitral Contour System® Case Presentation

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Long-term antithrombotic therapy in high-risk PCI patients

Optimal LDL levels in patients with ACS undergoing PCI

Ultra LOW LDL is the target for high risk patients

Optimal LDL Levels In Patients With ACS Undergoing PCI Clinical Case: PCI In ACS Patients With Multivessel Disease

Tips And Tricks In Retrograde CTO PCI

Antegrade Tips & Tricks

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Technical innovations in CTO

PCI in a NSTEMI patient When less is more…

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

The Abluminus DES+: from the technical features to the clinical program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content